PHM
58
6
HPE
52
-2
MU
80
-6
HPQ
25
4
UHS
56
2
RHI
42
2
SHW
45
3
TSCO
48
5
BAX
47
2
PEP
32
5
AME
72
-2
NUE
64
3
WFC
72
3
JNJ
62
-4
TXN
49
3
EL
67
11
AMAT
58
-2
MCK
64
-3
HIG
64
5
MAS
58
7
PHM
58
6
HPE
52
-2
MU
80
-6
HPQ
25
4
UHS
56
2
RHI
42
2
SHW
45
3
TSCO
48
5
BAX
47
2
PEP
32
5
AME
72
-2
NUE
64
3
WFC
72
3
JNJ
62
-4
TXN
49
3
EL
67
11
AMAT
58
-2
MCK
64
-3
HIG
64
5
MAS
58
7
Financhill
Back

First Citizens BancShares, Inc. (North Carolina) Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
50

FCNCA
First Citizens BancShares, Inc. (North Carolina)

Last Price:
$2,174.90
Seasonality Move:
3.21%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.24
Seasonality Move:
-11.9%
Sell
50
First Citizens BancShares, Inc. (North Carolina) (FCNCA) is a Sell

Is First Citizens BancShares, Inc. (North Carolina) a Buy, Sell or Hold?

  • The current First Citizens BancShares, Inc. (North Carolina) [FCNCA] share price is $2,177.72. The Score for FCNCA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • FCNCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCNCA Stock Price Chart

What is First Citizens BancShares, Inc. (North Carolina)'s stock price today?

  • The First Citizens BancShares, Inc. (North Carolina) share price today is $2,177.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCNCA is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

FCNCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 61.58 Buy
Relative Strength Index (14 RSI): 70 Buy
Chaikin Money Flow: -9733 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2022.23 - 2183.51) Buy
Bollinger Bands (100): (1771.61 - 2050.95) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

FCNCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2168.22 Buy
20-day SMA: 2137.95 Buy
50-day SMA: 1966.32 Buy
200-day SMA: 1897.51 Buy
8-day EMA: 2168.1 Buy
20-day EMA: 2120.8 Buy
50-day EMA: 2016.77 Buy
200-day EMA: 1929.97 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

First Citizens BancShares, Inc. (North Carolina) Earnings Growth & FCNCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $9.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.19 per share, and an increase next year of $22.29 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

First Citizens BancShares, Inc. (North Carolina) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):